Palvella Therapeutics (PVLA) Short-term Investments (2017 - 2023)
Historic Short-term Investments for Palvella Therapeutics (PVLA) over the last 6 years, with Q4 2023 value amounting to $9.0 million.
- Palvella Therapeutics' Short-term Investments fell 5631.64% to $9.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $9.0 million, marking a year-over-year decrease of 5631.64%. This contributed to the annual value of $9.0 million for FY2023, which is 5631.64% down from last year.
- Latest data reveals that Palvella Therapeutics reported Short-term Investments of $9.0 million as of Q4 2023, which was down 5631.64% from $11.9 million recorded in Q3 2023.
- In the past 5 years, Palvella Therapeutics' Short-term Investments ranged from a high of $58.7 million in Q1 2019 and a low of $8.6 million during Q1 2023
- Its 4-year average for Short-term Investments is $26.5 million, with a median of $21.4 million in 2022.
- In the last 5 years, Palvella Therapeutics' Short-term Investments soared by 1722.7% in 2019 and then tumbled by 6275.35% in 2023.
- Quarter analysis of 4 years shows Palvella Therapeutics' Short-term Investments stood at $41.9 million in 2019, then crashed by 62.41% to $15.8 million in 2020, then soared by 30.37% to $20.5 million in 2022, then tumbled by 56.32% to $9.0 million in 2023.
- Its last three reported values are $9.0 million in Q4 2023, $11.9 million for Q3 2023, and $9.9 million during Q2 2023.